Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery.

Poser SW, Otto O, Arps-Forker C, Ge Y, Herbig M, Andree C, Gruetzmann K, Adasme MF, Stodolak S, Nikolakopoulou P, Park DM, Mcintyre A, Lesche M, Dahl A, Lennig P, Bornstein SR, Schroeck E, Klink B, Leker RR, Bickle M, Chrousos GP, Schroeder M, Cannistraci CV, Guck J, Androutsellis-Theotokis A.

FASEB J. 2019 Aug;33(8):9235-9249. doi: 10.1096/fj.201802603RR. Epub 2019 May 30.

PMID:
31145643
2.

Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors.

Reinecke M, Ruprecht B, Poser S, Wiechmann S, Wilhelm M, Heinzlmeir S, Kuster B, Médard G.

ACS Chem Biol. 2019 Apr 19;14(4):655-664. doi: 10.1021/acschembio.8b01020. Epub 2019 Apr 3.

PMID:
30901187
3.

Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults.

Hurley LP, Allison MA, Kim L, O'Leary ST, Crane LA, Brtnikova M, Beaty BL, Allen KE, Poser S, Lindley MC, Kempe A.

Vaccine. 2019 Jan 21;37(4):565-570. doi: 10.1016/j.vaccine.2018.12.031. Epub 2018 Dec 28.

PMID:
30598385
4.

Survey of diagnostic testing for respiratory syncytial virus (RSV) in adults: Infectious disease physician practices and implications for burden estimates.

Allen KE, Beekmann SE, Polgreen P, Poser S, St Pierre J, Santibañez S, Gerber SI, Kim L.

Diagn Microbiol Infect Dis. 2018 Nov;92(3):206-209. doi: 10.1016/j.diagmicrobio.2017.12.011. Epub 2017 Dec 21.

PMID:
30177420
5.

Streptozotocin-induced β-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brain.

Nikolakopoulou P, Chatzigeorgiou A, Kourtzelis I, Toutouna L, Masjkur J, Arps-Forker C, Poser SW, Rozman J, Rathkolb B, Aguilar-Pimentel JA; German Mouse Clinic Consortium, Wolf E, Klingenspor M, Ollert M, Schmidt-Weber C, Fuchs H, Gailus-Durner V, Hrabe de Angelis M, Tsata V, Monasor LS, Troullinaki M, Witt A, Anastasiou V, Chrousos G, Yi CX, García-Cáceres C, Tschöp MH, Bornstein SR, Androutsellis-Theotokis A.

Sci Rep. 2018 Jul 27;8(1):11335. doi: 10.1038/s41598-018-29434-2.

6.

Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.

Gonçalves DPN, Rodriguez RD, Kurth T, Bray LJ, Binner M, Jungnickel C, Gür FN, Poser SW, Schmidt TL, Zahn DRT, Androutsellis-Theotokis A, Schlierf M, Werner C.

Acta Biomater. 2017 Aug;58:12-25. doi: 10.1016/j.actbio.2017.05.054. Epub 2017 May 31.

PMID:
28576716
7.

Enlightening discriminative network functional modules behind Principal Component Analysis separation in differential-omic science studies.

Ciucci S, Ge Y, Durán C, Palladini A, Jiménez-Jiménez V, Martínez-Sánchez LM, Wang Y, Sales S, Shevchenko A, Poser SW, Herbig M, Otto O, Androutsellis-Theotokis A, Guck J, Gerl MJ, Cannistraci CV.

Sci Rep. 2017 Mar 13;7:43946. doi: 10.1038/srep43946.

8.

Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.

Toutouna L, Nikolakopoulou P, Poser SW, Masjkur J, Arps-Forker C, Troullinaki M, Grossklaus S, Bosak V, Friedrich U, Ziemssen T, Bornstein SR, Chavakis T, Androutsellis-Theotokis A.

Brain Res. 2016 Jul 1;1642:124-130. doi: 10.1016/j.brainres.2016.03.014. Epub 2016 Mar 25.

PMID:
27018293
9.

Endocrine Pancreas Development and Regeneration: Noncanonical Ideas From Neural Stem Cell Biology.

Masjkur J, Poser SW, Nikolakopoulou P, Chrousos G, McKay RD, Bornstein SR, Jones PM, Androutsellis-Theotokis A.

Diabetes. 2016 Feb;65(2):314-30. doi: 10.2337/db15-1099.

10.

STAT3-Ser/Hes3 Signaling: A New Molecular Component of the Neuroendocrine System?

Nikolakopoulou P, Poser SW, Masjkur J, Fernandez Rubin de Celis M, Toutouna L, Andoniadou CL, McKay RD, Chrousos G, Ehrhart-Bornstein M, Bornstein SR, Androutsellis-Theotokis A.

Horm Metab Res. 2016 Feb;48(2):77-82. doi: 10.1055/s-0041-111699. Epub 2016 Jan 19. Review.

PMID:
26783739
11.

Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications.

Poser SW, Chenoweth JG, Colantuoni C, Masjkur J, Chrousos G, Bornstein SR, McKay RD, Androutsellis-Theotokis A.

Stem Cells Transl Med. 2015 Nov;4(11):1251-7. doi: 10.5966/sctm.2015-0105. Epub 2015 Sep 14. Review.

12.

CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014.

Williams HA, Dunville RL, Gerber SI, Erdman DD, Pesik N, Kuhar D, Mason KA, Haynes L, Rotz L, St Pierre J, Poser S, Bunga S, Pallansch MA, Swerdlow DL; MERS-CoV Working Group.

Public Health Rep. 2015 Jul-Aug;130(4):307-17.

13.

Deleterious effects of obesity on physical fitness in pre-pubertal children.

Ceschia A, Giacomini S, Santarossa S, Rugo M, Salvadego D, Da Ponte A, Driussi C, Mihaleje M, Poser S, Lazzer S.

Eur J Sport Sci. 2016;16(2):271-8. doi: 10.1080/17461391.2015.1030454. Epub 2015 Apr 13.

PMID:
25866877
14.

Spicing up endogenous neural stem cells: aromatic-turmerone offers new possibilities for tackling neurodegeneration.

Poser SW, Androutsellis-Theotokis A.

Stem Cell Res Ther. 2014 Nov 17;5(6):127. doi: 10.1186/scrt517.

15.

Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin release.

Masjkur J, Arps-Forker C, Poser SW, Nikolakopoulou P, Toutouna L, Chenna R, Chavakis T, Chatzigeorgiou A, Chen LS, Dubrovska A, Choudhary P, Uphues I, Mark M, Bornstein SR, Androutsellis-Theotokis A.

J Biol Chem. 2014 Dec 19;289(51):35503-16. doi: 10.1074/jbc.M114.590687. Epub 2014 Nov 4.

16.

Methods for assessing the regenerative responses of neural tissue.

Poser SW, Rueger MA, Androutsellis-Theotokis A.

Methods Mol Biol. 2014;1213:293-302. doi: 10.1007/978-1-4939-1453-1_24.

PMID:
25173392
17.

A defined, controlled culture system for primary bovine chromaffin progenitors reveals novel biomarkers and modulators.

Masjkur J, Levenfus I, Lange S, Arps-Forker C, Poser S, Qin N, Vukicevic V, Chavakis T, Eisenhofer G, Bornstein SR, Ehrhart-Bornstein M, Androutsellis-Theotokis A.

Stem Cells Transl Med. 2014 Jul;3(7):801-8. doi: 10.5966/sctm.2013-0211. Epub 2014 May 22.

18.

The STAT3-Ser/Hes3 signaling axis in cancer.

Poser SW, Park DM, Androutsellis-Theotokis A.

Front Biosci (Landmark Ed). 2014 Jan 1;19:718-26. Review.

PMID:
24389215
19.

Growing neural stem cells from conventional and nonconventional regions of the adult rodent brain.

Poser SW, Androutsellis-Theotokis A.

J Vis Exp. 2013 Nov 18;(81):e50880. doi: 10.3791/50880.

20.

The STAT3-Ser/Hes3 signaling axis: an emerging regulator of endogenous regeneration and cancer growth.

Poser SW, Park DM, Androutsellis-Theotokis A.

Front Physiol. 2013 Oct 1;4:273. doi: 10.3389/fphys.2013.00273. eCollection 2013.

21.

Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics.

Park DM, Jung J, Masjkur J, Makrogkikas S, Ebermann D, Saha S, Rogliano R, Paolillo N, Pacioni S, McKay RD, Poser S, Androutsellis-Theotokis A.

Sci Rep. 2013;3:1095. doi: 10.1038/srep01095. Epub 2013 Feb 5.

22.

Whole-body glucose oxidation rate during prolonged exercise in type 1 diabetic patients under usual life conditions.

Geat M, Stel G, Poser S, Driussi C, Stenner E, Francescato MP.

Metabolism. 2013 Jun;62(6):836-44. doi: 10.1016/j.metabol.2013.01.004. Epub 2013 Jan 31.

PMID:
23375550
23.

p53 controls neuronal death in the CA3 region of the newborn mouse hippocampus.

Murase S, Poser SW, Joseph J, McKay RD.

Eur J Neurosci. 2011 Aug;34(3):374-81. doi: 10.1111/j.1460-9568.2011.07758.x. Epub 2011 Jun 30.

PMID:
21714817
24.

Prolonged nocturnal asystole and cerebral neurogliosis in a marathon runner.

Slavich G, Poser S, Antonutto G, Fregolent R, Piccoli G, di Prampero PE.

J Cardiovasc Med (Hagerstown). 2011 Dec;12(12):901-3. doi: 10.2459/JCM.0b013e32833b91ff. No abstract available.

PMID:
20531211
25.

Energy cost and metabolic power in elite soccer: a new match analysis approach.

Osgnach C, Poser S, Bernardini R, Rinaldo R, di Prampero PE.

Med Sci Sports Exerc. 2010 Jan;42(1):170-8. doi: 10.1249/MSS.0b013e3181ae5cfd.

PMID:
20010116
26.

Targeting neural precursors in the adult brain rescues injured dopamine neurons.

Androutsellis-Theotokis A, Rueger MA, Park DM, Mkhikian H, Korb E, Poser SW, Walbridge S, Munasinghe J, Koretsky AP, Lonser RR, McKay RD.

Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13570-5. doi: 10.1073/pnas.0905125106. Epub 2009 Jul 23.

27.

Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.

Poser S.

Food Drug Law J. 2007;62(4):653-94. No abstract available.

PMID:
18557225
28.

Release of dibenzoyl peroxide from polymethyl methacrylate denture base resins: an in vitro evaluation.

Boeckler AF, Morton D, Poser S, Dette KE.

Dent Mater. 2008 Dec;24(12):1602-7. doi: 10.1016/j.dental.2008.03.019. Epub 2008 May 8.

PMID:
18471871
29.

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.

Mollenhauer B, Steinacker P, Bahn E, Bibl M, Brechlin P, Schlossmacher MG, Locascio JJ, Wiltfang J, Kretzschmar HA, Poser S, Trenkwalder C, Otto M.

Neurodegener Dis. 2007;4(5):366-75. Epub 2007 Jul 6.

PMID:
17622779
30.

Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences.

Kallenberg K, Schulz-Schaeffer WJ, Jastrow U, Poser S, Meissner B, Tschampa HJ, Zerr I, Knauth M.

AJNR Am J Neuroradiol. 2006 Aug;27(7):1459-62.

31.

Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia.

Mollenhauer B, Trenkwalder C, von Ahsen N, Bibl M, Steinacker P, Brechlin P, Schindehuette J, Poser S, Wiltfang J, Otto M.

Dement Geriatr Cogn Disord. 2006;22(3):200-8. Epub 2006 Aug 7.

PMID:
16899997
32.

Notch signalling regulates stem cell numbers in vitro and in vivo.

Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW, Rueger MA, Bae SK, Kittappa R, McKay RD.

Nature. 2006 Aug 17;442(7104):823-6. Epub 2006 Jun 25.

PMID:
16799564
33.

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease.

Mollenhauer B, Bibl M, Trenkwalder C, Stiens G, Cepek L, Steinacker P, Ciesielczyk B, Neubert K, Wiltfang J, Kretzschmar HA, Poser S, Otto M.

J Neural Transm (Vienna). 2005 Jul;112(7):933-48. Epub 2004 Nov 24.

PMID:
15937638
34.

Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.

Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, Cuesta Jde P, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I.

Neurology. 2005 May 10;64(9):1586-91.

PMID:
15883321
35.

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Cepek L, Steinacker P, Mollenhauer B, Wiese B, Ciesielczyk B, Bibl M, Wiltfang J, Zerr I, Schulz-Schaeffer W, Kretzschmar HA, Poser S, Otto M.

Dement Geriatr Cogn Disord. 2005;19(5-6):376-82. Epub 2005 Mar 30.

PMID:
15802913
36.

Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease.

Jacobi C, Arlt S, Reiber H, Westner I, Kretzschmar HA, Poser S, Zerr I.

Acta Neurol Scand. 2005 Mar;111(3):185-90.

PMID:
15691288
37.

Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.

Bitsch A, Dressel A, Meier K, Bogumil T, Deisenhammer F, Tumani H, Kitze B, Poser S, Weber F.

J Neurol. 2004 Dec;251(12):1498-501.

PMID:
15645350
38.

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

Mollenhauer B, Cepek L, Bibl M, Wiltfang J, Schulz-Schaeffer WJ, Ciesielczyk B, Neumann M, Steinacker P, Kretzschmar HA, Poser S, Trenkwalder C, Otto M.

Dement Geriatr Cogn Disord. 2005;19(2-3):164-70. Epub 2005 Jan 5.

PMID:
15637452
39.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group.

J Neurol. 2004 Nov;251(11):1329-39. Review.

PMID:
15592728
40.

Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis.

Bitsch A, Bahner D, Wachter C, Elitok E, Bogumil T, Dressel A, Polak T, Tumani H, Weber F, Poser S, Kitze B.

Acta Neurol Scand. 2004 Dec;110(6):386-92.

PMID:
15527451
41.

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

Steinacker P, Mollenhauer B, Bibl M, Cepek L, Esselmann H, Brechlin P, Lewczuk P, Poser S, Kretzschmar HA, Wiltfang J, Trenkwalder C, Otto M.

Neurosci Lett. 2004 Nov 3;370(1):36-9.

PMID:
15489013
42.

Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.

Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA.

Ann Neurol. 2004 Nov;56(5):702-8.

PMID:
15449324
43.

Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.

Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, Brandel JP, Alperovitch A, Zerr I, Poser S, Kretzschmar HA, Ladogana A, Rietvald I, Mitrova E, Martinez-Martin P, de Pedro-Cuesta J, Glatzel M, Aguzzi A, Cooper S, Mackenzie J, van Duijn CM, Will RG.

Brain. 2004 Oct;127(Pt 10):2348-59. Epub 2004 Sep 10.

44.

Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings.

Meissner B, Körtner K, Bartl M, Jastrow U, Mollenhauer B, Schröter A, Finkenstaedt M, Windl O, Poser S, Kretzschmar HA, Zerr I.

Neurology. 2004 Aug 10;63(3):450-6.

PMID:
15314808
45.

Epidemiology and risk factors of transmissible spongiform encephalopathies in man.

Zerr I, Poser S.

Contrib Microbiol. 2004;11:98-116. Review. No abstract available.

PMID:
15077405
46.

Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.

Otto M, Cepek L, Ratzka P, Doehlinger S, Boekhoff I, Wiltfang J, Irle E, Pergande G, Ellers-Lenz B, Windl O, Kretzschmar HA, Poser S, Prange H.

Neurology. 2004 Mar 9;62(5):714-8.

PMID:
15007119
47.

A novel role for serum response factor in neuronal survival.

Chang SH, Poser S, Xia Z.

J Neurosci. 2004 Mar 3;24(9):2277-85.

48.

CSF lactate dehydrogenase activity in patients with Creutzfeldt-Jakob disease exceeds that in other dementias.

Schmidt H, Otto M, Niedmann P, Cepek L, Schröter A, Kretzschmar HA, Poser S.

Dement Geriatr Cogn Disord. 2004;17(3):204-6. Epub 2004 Jan 20.

PMID:
14739545
49.

Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.

Yushchenko M, Mäder M, Elitok E, Bitsch A, Dressel A, Tumani H, Bogumil T, Kitze B, Poser S, Weber F.

J Neurol. 2003 Oct;250(10):1224-8.

PMID:
14586607
50.

Latrogenic Creutzfeldt-Jakob disease with florid plaques.

Kretzschmar HA, Sethi S, Földvári Z, Windl O, Querner V, Zerr I, Poser S.

Brain Pathol. 2003 Jul;13(3):245-9. Review.

PMID:
12946015

Supplemental Content

Support Center